Skip to main content
. 2009 Oct 12;4(10):e7415. doi: 10.1371/journal.pone.0007415

Figure 3. Effect of NSC23925 to reverse drug resistance in MDR cell lines.

Figure 3

Cells were treated with the paclitaxel and NSC23925 in RPMI1640 complete media at the indicated concentrations. The relative sensitivity of each line to paclitaxe was determined by MTT analysis 6 days posttreatment. A: Reversal of paclitaxel resistance by NSC23925 in SKOV-3TR cells. B: Reversal of paclitaxel resistance by NSC23925 in OVCAR8TR cells.